Tributary Capital Management LLC Decreases Stake in Integer Holdings Co. (NYSE:ITGR)

Tributary Capital Management LLC lessened its holdings in shares of Integer Holdings Co. (NYSE:ITGR) by 0.4% during the third quarter, according to the company in its most recent Form 13F filing with the SEC. The firm owned 285,236 shares of the medical equipment provider’s stock after selling 1,213 shares during the period. Integer accounts for 2.9% of Tributary Capital Management LLC’s holdings, making the stock its biggest holding. Tributary Capital Management LLC owned about 0.85% of Integer worth $37,081,000 as of its most recent SEC filing.

A number of other institutional investors and hedge funds have also added to or reduced their stakes in ITGR. Contravisory Investment Management Inc. boosted its position in Integer by 55.9% during the third quarter. Contravisory Investment Management Inc. now owns 223 shares of the medical equipment provider’s stock worth $29,000 after purchasing an additional 80 shares during the period. Quest Partners LLC lifted its stake in Integer by 3,688.9% in the second quarter. Quest Partners LLC now owns 341 shares of the medical equipment provider’s stock worth $39,000 after acquiring an additional 332 shares during the period. GAMMA Investing LLC lifted its stake in shares of Integer by 60.9% in the 2nd quarter. GAMMA Investing LLC now owns 375 shares of the medical equipment provider’s stock valued at $43,000 after purchasing an additional 142 shares during the period. Headlands Technologies LLC purchased a new stake in shares of Integer in the 1st quarter worth about $106,000. Finally, Innealta Capital LLC bought a new position in shares of Integer during the second quarter valued at approximately $110,000. Institutional investors and hedge funds own 99.29% of the company’s stock.

Wall Street Analyst Weigh In

ITGR has been the subject of a number of recent analyst reports. Citigroup boosted their target price on Integer from $124.00 to $130.00 and gave the stock a “neutral” rating in a research report on Tuesday, October 1st. Bank of America raised their target price on shares of Integer from $135.00 to $145.00 and gave the stock a “buy” rating in a report on Tuesday, October 1st. Benchmark boosted their target price on shares of Integer from $130.00 to $140.00 and gave the company a “buy” rating in a research note on Monday, October 21st. KeyCorp raised their price objective on Integer from $139.00 to $144.00 and gave the stock an “overweight” rating in a research note on Tuesday, October 15th. Finally, Oppenheimer assumed coverage on shares of Integer in a report on Tuesday, July 16th. They issued an “outperform” rating and a $135.00 target price for the company. One research analyst has rated the stock with a hold rating and seven have given a buy rating to the stock. According to MarketBeat, the company currently has a consensus rating of “Moderate Buy” and an average target price of $139.75.

Integer Stock Performance

NYSE:ITGR opened at $125.77 on Monday. The company has a debt-to-equity ratio of 0.73, a quick ratio of 1.96 and a current ratio of 3.29. The stock’s fifty day moving average is $127.58 and its 200 day moving average is $121.03. The firm has a market capitalization of $4.22 billion, a PE ratio of 41.10, a PEG ratio of 1.80 and a beta of 1.08. Integer Holdings Co. has a fifty-two week low of $73.40 and a fifty-two week high of $133.53.

Integer (NYSE:ITGR) last posted its quarterly earnings data on Thursday, October 24th. The medical equipment provider reported $1.43 earnings per share (EPS) for the quarter, beating analysts’ consensus estimates of $1.36 by $0.07. Integer had a return on equity of 11.48% and a net margin of 6.31%. The company had revenue of $431.42 million during the quarter, compared to analysts’ expectations of $440.59 million. During the same quarter in the previous year, the business earned $1.27 EPS. Integer’s revenue was up 8.7% compared to the same quarter last year. On average, sell-side analysts anticipate that Integer Holdings Co. will post 5.3 earnings per share for the current year.

Insider Buying and Selling

In other Integer news, Director Jean M. Hobby sold 11,960 shares of the business’s stock in a transaction dated Wednesday, July 31st. The stock was sold at an average price of $119.66, for a total transaction of $1,431,133.60. Following the sale, the director now owns 2,280 shares in the company, valued at approximately $272,824.80. The trade was a 0.00 % decrease in their position. The transaction was disclosed in a document filed with the Securities & Exchange Commission, which can be accessed through the SEC website. 2.00% of the stock is owned by company insiders.

About Integer

Integer Holdings Corporation operates as a medical device outsource manufacturer in the United States, Puerto Rico, Costa Rica, and internationally. It operates through two segments, Medical and Non-Medical. The company offers products for interventional cardiology, structural heart, heart failure, peripheral vascular, neurovascular, interventional oncology, electrophysiology, vascular access, infusion therapy, hemodialysis, non-vascular, urology, and gastroenterology procedures.